病棟指示と頻用薬の使い方　決定版

出版社： 羊土社
著者：
発行日： 2023-01-01
分野： 臨床医学：内科  >  内科学一般
ISBN： 9784758123976
電子書籍版： 2023-01-01 （第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

4,950 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,950 円(税込)

購入する

商品紹介

歴代No.1のレジデントノートの特集が超パワーアップ！持参薬やマイナートラブルなど，病棟での必須な知識を加えてより充実．最適な指示のための考え方から，その後のDr.Callまでがよくわかる1冊．

目次

  • ● はじめに
    ● 知っておきたい！　病棟当直管理上の教訓

    Part1　病棟指示と頻用薬の使い方
    　1．病棟指示の考え方
    　2A．バイタル測定の指示
    　2B．安静度の指示
    　2C．食事の指示
    　3．発熱時の指示
    　4．疼痛時の指示
    　5．SpO2低下時の指示
    　　　+α　HFNCとNPPVの適応　～病棟でどう使う？
    　6．血圧（高血圧時・低血圧時）の指示
    　7．脈拍（頻脈時・徐脈時）の指示
    　8．血糖（高血糖時・低血糖時）の指示
    　9．嘔気・嘔吐時の指示
    　10．便秘時の指示
    　　　+α　非刺激性下剤の特徴と使い分け
    　11．不眠時・不穏時の指示
    　12．急変時の指示　―DNARの指し示す本当の意味とは？
    　13．入院中の予防指示

    Part2　持参薬はどうする？　―基礎疾患のある患者の病棟管理
    　1．持参薬の考え方
    　2．循環器
    　3．消化器
    　　+α　肝炎ウイルス検査とその対応
    　4．呼吸器
    　5．神経
    　6．内分泌・代謝
    　7．血液・腫瘍
    　8．腎臓・透析
    　　+α　透析中の患者さんが入院してきたときのルーティンアプローチ
    　9．膠原病
    　　+α　各種薬剤の副作用を掴もう！
    　10．精神

    Part3　病棟でのマイナートラブル
    　1．病棟でのマイナートラブル
    　2．病棟で転んだ，ベッドから落ちた
    　3．尿道カテーテル留置
    　4．経鼻胃管が入らない
    　5．胃瘻カテーテルが抜けた
    　6．入院中に下痢をした
    　　+α　CDI検査 今昔物語
    　7．痙攣の初期対応

    付録　薬剤便利帖
    　付録1　腎機能により投与量を調節する医薬品一覧
    　付録2　注射薬の筋肉注射の可否一覧
    　付録3　簡易懸濁可能な薬剤とできない薬剤
    　付録4　その他，投与の際に注意が必要な医薬品一覧
    　付録5　投与時に血中濃度測定が必要な主な医薬品

    ● おわりに

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

Part 1 病棟指示と頻用薬の使い方

P.20 掲載の参考文献
1) 「Goldman-Cecil Medicine, 26th ed., in 2 vols」 (L.Goldman & A.I.Schafer, eds), ELSEVIER, 2020
 
2) Andersen LW, et al : The prevalence and significance of abnormal vital signs prior to in-hospital cardiac arrest. Resuscitation, 98 : 112-117, 2016 (PMID : 26362486)
 
3) Fieselmann JF, et al : Respiratory rate predicts cardiopulmonary arrest for internal medicine inpatients. J Gen Intern Med, 8 : 354-360, 1993 (PMID : 8410395)
 
4) Zeitz K & McCutcheon H : Evidence-based practice : to be or not to be, this is the question! Int J Nurs Pract, 9 : 272-279, 2003 (PMID : 14531848)
 
5) Dall'Ora C, et al : What is the nursing time and workload involved in taking and recording patients' vital signs? A systematic review. J Clin Nurs, 29 : 2053-2068, 2020 (PMID : 32017272)
 
6) Kamio T, et al : Frequency of vital sign measurement among intubated patients in the general ward and nurses' attitudes toward vital sign measurement. J Multidiscip Healthc, 11 : 575-581, 2018 (PMID : 30410344)
 
7) Hemphill JC 3rd, et al : Guidelines for the Management of Spontaneous Intracerebral Hemorrhage : A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 46 : 2032-2060, 2015 (PMID : 26022637)
 
8) Global Initiative for Chronic Obstructive Lung Disease (GOLD) : GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD : 2022 Report https://goldcopd.org/2022-gold-reports/
 
9) Hindricks G, et al : 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) : The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J, 42 : 373-498, 2021 (PMID : 32860505) https://doi.org/10.1093/eurheartj/ehaa612
 
10) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会合同ガイドライン : 2020年改訂版 大動脈瘤・大動脈解離診療ガイドライン https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf
 
11) Powers WJ, et al : Guidelines for the Early Management of Patients With Acute Ischemic Stroke : 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke : A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 50 : e344-e418, 2019 (PMID : 31662037)
 
12) Reddel HK, et al : Global Initiative for Asthma Strategy 2021 : Executive Summary and Rationale for Key Changes. Am J Respir Crit Care Med, 205 : 17-35, 2022 (PMID : 34658302)
 
13) Evans L, et al : Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 47 : 1181-1247, 2021 (PMID : 34599691)
 
P.25 掲載の参考文献
1) 園田茂 : 不動・廃用症候群. Jpn J Rehabil Med. 52 (4-5) : 265-271, 2015
 
2) Kleinpell RM, et al : Reducing Functional Decline in Hospitalized Elderly. 「Patient Safety and Quality : An Evidence-Based Handbook for Nurses」 (Hughes RG, eds), 2008 (PMID : 21328732)
 
3) 前田真治 : リハビリテーション医療における 安全管理・推進のためのガイドライン. Jpn J Rehabil Med. 44 (7) : 384-390, 2007
Medical*Online
4) Powers WJ, et al : Guidelines for the Early Management of Patients With Acute Ischemic Stroke : 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke : A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 50 : e344-e418, 2019 (PMID : 31662037)
 
5) 一般社団法人日本脳卒中学会 脳卒中ガイドライン委員会 : 脳卒中治療ガイドライン 2021
 
6) Schwarz S, et al : Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke, 33 : 497-501, 2002 (PMID : 11823659)
 
7) Drakulovic MB, et al : Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients : a randomised trial. Lancet, 354 : 1851-1858, 1999 (PMID : 10584721)
 
8) Loeb MB, et al : Interventions to prevent aspiration pneumonia in older adults : a systematic review. J Am Geriatr Soc, 51 : 1018-1022, 2003 (PMID : 12834525)
 
9) 吉本和樹 : 施設で排泄援助を受ける高齢者の体験. 老年看護学. 13 (1) : 57-64, 2008
Medical*Online
10) Hayasaka S, et al : Bathing in a bathtub and health status : a cross-sectional study. Complement Ther Clin Pract, 16 : 219-221, 2010 (PMID : 20920807)
 
11) Suzuki M, et al : Sudden Death Phenomenon While Bathing in Japan - Mortality Data. Circ J, 81 : 1144-1149, 2017 (PMID : 28392545)
 
12) 大塚吉則 : 特集 正しい入浴法のすすめ 入浴の生理学. JIM 10 (10), 830-834, 2000
 
13) 鈴木昌 : 環境温度が与える生体への負荷と環境障害. 日内会誌. 108 (12) : 2443-2453, 2019
 
14) Nakagawa R, et al : Drowning of a patient with epilepsy while showering. Environ Health Prev Med, 24 : 31, 2019 (PMID : 31084599)
 
P.28 掲載の参考文献
1) Maeda K, et al : Tentative nil per os leads to poor outcomes in older adults with aspiration pneumonia. Clin Nutr, 35 : 1147-1152, 2016 (PMID : 26481947)
 
2) 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会 : 日本版重症患者の栄養療法ガイドライン. 日集中医誌. 23 (2) : 185-281, 2016
 
3) 日本介護食品協議会 : ユニバーサルデザインフードとは https://www.udf.jp/outline/udf.html
 
4) 日本摂食嚥下リハビリテーション学会嚥下調整食委員会 : 日本摂食嚥下リハビリテーション学会嚥下調整食分類 2021. 日摂食嚥下リハ会誌. 25 (2) : 135-149, 2021
 
5) Newman R, et al : Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the Swallow Response in Patients with Oropharyngeal Dysphagia : White Paper by the European Society for Swallowing Disorders (ESSD). Dysphagia, 31 : 232-249, 2016 (PMID : 27016216)
 
P.34 掲載の参考文献
1) Schell-Chaple HM, et al : Effects of IV Acetaminophen on Core Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults : A Randomized Controlled Trial. Crit Care Med, 45 : 1199-1207, 2017 (PMID : 28319467)
 
2) Shah NG, et al : Nonpharmacologic approach to minimizing shivering during surface cooling : a proof of principle study. J Crit Care, 27 : 746.e1-746.e8, 2012 (PMID : 22762936)
 
3) Schortgen F, et al : Fever control using external cooling in septic shock : a randomized controlled trial. Am J Respir Crit Care Med, 185 : 1088-1095, 2012 (PMID : 22366046)
 
4) Freund Y, et al : Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department. JAMA, 317 : 301-308, 2017 (PMID : 28114554)
 
5) Evans L, et al : Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 47 : 1181-1247, 2021 (PMID : 34599691)
 
6) Boyer EW & Shannon M : The serotonin syndrome. N Engl J Med, 352 : 1112-1120, 2005 (PMID : 15784664)
 
志馬伸朗 : Part 7 1. 体温の生理学―その熱は下げるべきか?. INTENSIVIST, 12 : 189-194, 2020
 
P.41 掲載の参考文献
1) Martucci KT & Mackey SC : Neuroimaging of Pain : Human Evidence and Clinical Relevance of Central Nervous System Processes and Modulation. Anesthesiology, 128 : 1241-1254, 2018 (PMID : 29494401)
 
2) Baral P, et al : Pain and immunity : implications for host defence. Nat Rev Immunol, 19 : 433-447, 2019 (PMID : 30874629)
 
3) Jozwiak-Bebenista M & Nowak JZ : Paracetamol : mechanism of action, applications and safety concern. Acta Pol Pharm, 71 : 11-23, 2014 (PMID : 24779190)
 
4) Krajcova A, et al : Mechanism of paracetamol-induced hypotension in critically ill patients : a prospective observational cross-over study. Aust Crit Care, 26 : 136-141, 2013 (PMID : 22424816)
 
5) Cantais A, et al : Acetaminophen-Induced Changes in Systemic Blood Pressure in Critically Ill Patients : Results of a Multicenter Cohort Study. Crit Care Med, 44 : 2192-2198, 2016 (PMID : 27414476)
 
6) Farkouh ME, et al : Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis, 66 : 764-770, 2007 (PMID : 17412741)
 
P.48 掲載の参考文献
1) 日本呼吸器学会 : Q& A パルスオキシメータハンドブック, 2014 https://www.jrs.or.jp/file/pulse-oximeter_medical.pdf
 
2) コニカミノルタ : パルスオキシメーターの原理 https://www.konicaminolta.jp/healthcare/knowledge/details/principle.html
 
3) 日本光電 : プローブ装着のポイント https://www.nihonkohden.co.jp/iryo/point/spo2point/point.html
 
4) Girardis M, et al : Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit : The Oxygen-ICU Randomized Clinical Trial. JAMA, 316 : 1583-1589, 2016 (PMID : 27706466)
 
5) Chu DK, et al : Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA) : a systematic review and meta-analysis. Lancet, 391 : 1693-1705, 2018 (PMID : 29726345)
 
6) Siemieniuk RAC, et al : Oxygen therapy for acutely ill medical patients : a clinical practice guideline. BMJ, 363 : k4169, 2018 (PMID : 30355567)
 
7) O'Drisoll BR, et al : BTS Guideline for oxygen use in adults in healthcare and emergency settings. Thorax, 72 : ii1-ii90, 2017 (PMID : 28507176)
 
P.59 掲載の参考文献
1) Brooks TW, et al : Blood pressure management in acute hypertensive emergency. Am J Health Syst Pharm, 64 : 2579-2582, 2007 (PMID : 18056947)
 
2) Anderson CS, et al : Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med, 368 : 2355-2365, 2013 (PMID : 23713578)
 
3) Qureshi AI, et al : Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med, 375 : 1033-1043, 2016 (PMID : 27276234)
 
4) Mebazaa A, et al : Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med, 36 : S129-S139, 2008 (PMID : 18158472)
 
5) Patel KK, et al : Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting. JAMA Intern Med, 176 : 981-988, 2016 (PMID : 27294333)
 
6) Fischberg GM, et al : Stroke precipitated by moderate blood pressure reduction. J Emerg Med, 19 : 339-346, 2000 (PMID : 11074327)
 
7) Rastogi R, et al : Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions. JAMA Intern Med, 181 : 345-352, 2021 (PMID : 33369614)
 
8) Neyra JA, et al : Cumulative Fluid Balance and Mortality in Septic Patients With or Without Acute Kidney Injury and Chronic Kidney Disease. Crit Care Med, 44 : 1891-1900, 2016 (PMID : 27352125)
 
9) Vincent JL & De Backer D : Circulatory shock. N Engl J Med, 369 : 1726-1734, 2013 (PMID : 24171518)
 
10) Myburgh JA & My then MG : Resuscitation f luids. N Engl J Med, 369 : 1243-1251, 2013 (PMID : 24066745)
 
11) Reddick AD, et al : Intravenous fluid resuscitation : was Poiseuille right? Emerg Med J, 28 : 201-202, 2011 (PMID : 20581377)
 
12) Venkatesh B, et al : Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med, 378 : 797-808, 2018 (PMID : 29347874)
 
13) Annane D, et al : Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med, 378 : 809-818, 2018 (PMID : 29490185)
 
14) De Backer D, et al : Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med, 362 : 779-789, 2010 (PMID : 20200382)
 
15) Levy B, et al : Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol, 72 : 173-182, 2018 (PMID : 29976291)
 
16) Leopold V, et al : Epinephrine and short-term survival in cardiogenic shock : an individual data meta-analysis of 2583 patients. Intensive Care Med, 44 : 847-856, 2018 (PMID : 29858926)
 
P.68 掲載の参考文献
1) 「そうだったのか! 絶対読める心電図」 (池田隆徳/著), 羊土社, 2011
 
2) Roy D, et al : Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med, 358 : 2667-2677, 2008 (PMID : 18565859)
 
3) Wyse DG, et al : A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 347 : 1825-1833, 2002 (PMID : 12466506)
 
4) Pluymaekers NAHA, et al : Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation. N Engl J Med, 380 : 1499-1508, 2019 (PMID : 30883054)
 
5) Wada Y, et al : Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction. J Arrhythm, 32 : 82-88, 2016 (PMID : 27092187)
 
6) Washam JB, et al : Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes : a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Lancet, 385 : 2363-2370, 2015 (PMID : 25749644)
 
7) 医學事始 : narrow QRS tachycardia http://igakukotohajime.com/
 
P.80 掲載の参考文献
1) American Diabetes Association : Standards of medical care in diabetes-2022. Diabetes Care, 45 : S1-S264, 2021 https://care.diabetesjournals.org/content/45/Supplement_1
 
2) Kavanagh BP & McCowen KC : Clinical practice. Glycemic control in the ICU. N Engl J Med, 363 : 2540-2546, 2010 (PMID : 21175316)
 
3) Glucose Control in Critical Care Patients With and Without Diabetes. DynaMed, 2018
 
4) McCulloch DK & Robertson RP : Pathogenesis of type 2 diabetes mellitus. UpToDate(R), 2019
 
5) McCulloch DK : Classification of diabetes mellitus and genetic diabetic syndromes. UpToDate(R), 2019
 
6) Umpierrez GE, et al : Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes : basal plus trial. Diabetes Care, 36 : 2169-2174, 2013 (PMID : 23435159)
 
7) Cryer PE, et al : Evaluation and management of adult hypoglycemic disorders : an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 94 : 709-728, 2009 (PMID : 19088155)
 
8) Stephen N, et al : Hypoglycemia and Hypoglycemic Syndromes. Endocrinology : Adult and Pediatric (seventh edition), Chapter 47, 816-838, Saunders, 2016
 
9) Khan NA, et al : Perioperative management of blood glucose in adults with diabetes mellitus. UpToDate(R), 2022
 
10) Pezzarossa A, et al : Perioperative management of diabetic subjects. Subcutaneous versus intravenous insulin administration during glucose-potassium infusion. Diabetes Care, 11 : 52-58, 1988 (PMID : 3276477)
 
11) Curkendall SM, et al : Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract, 15 : 302-312, 2009 (PMID : 19502209)
 
12) Umpierrez GE, et al : Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care, 34 : 256-261, 2011 (PMID : 21228246)
 
13) Kitabchi AE, et al : Hyperglycemic crises in diabetes. Diabetes Care, 27 Suppl 1 : S94-102, 2004 (PMID : 14693938)
 
P.89 掲載の参考文献
1) Wood GJ, et al : Management of intractable nausea and vomiting in patients at the end of life : "I was feeling nauseous all of the time... nothing was working". JAMA, 298 : 1196-1207, 2007 (PMID : 17848654)
 
2) Furyk JS, et al : Drug treatment of adults with nausea and vomiting in primary care. BMJ, 349 : g4714, 2014 (PMID : 25103458)
 
3) Tome J, et al : A Practical 5-Step Approach to Nausea and Vomiting. Mayo Clin Proc, 97 : 600-608, 2022 (PMID : 35246289)
 
4) 「がん患者の消化器症状の緩和に関するガイドライン 2017年版」 (特定非営利活動法人 日本緩和医療学会 ガイドライン統括委員会/編), 金原出版, 2017
 
5) Miller AD & Leslie RA : The area postrema and vomiting. Front Neuroendocrinol, 15 : 301-320, 1994 (PMID : 7895890)
 
6) Horn CC : Why is the neurobiology of nausea and vomiting so important? Appetite, 50 : 430-434, 2008 (PMID : 17996982)
 
7) Dhakal OP, et al : Domperidone-induced dystonia : a rare and troublesome complication. BMJ Case Rep, 2014 : doi : 10.1136/bcr-2013-200282, 2014 (PMID : 24973343)
 
8) 武井大輔, 他 : 嘔気・嘔吐の薬物療法. 日本緩和医療薬学雑誌, 2 : 111-117, 2009
 
9) 日本癌治療学会 : がん診療ガイドライン 制吐療法診療ガイドライン. http://jsco-cpg.jp/guideline/29.html
 
10) 協和キリン株式会社 : ナウゼリン(R) 錠 インタビューフォーム
 
11) Arana A, et al : Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide : A Population-Based Nested Case-Control Study. Drug Saf, 38 : 1187-1199, 2015 (PMID : 26350642)
PubMed
12) Parlak I, et al : Rate of metoclopramide infusion affects the severity and incidence of akathisia. Emerg Med J, 22 : 621-624, 2005 (PMID : 16113179)
 
13) Cavero-Redondo I, et al : Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration : a systematic review and meta-analysis of randomised controlled trials. J Clin Nurs, 24 : 3638-3646, 2015 (PMID : 26373874)
 
14) Quigley EM, et al : AGA technical review on nausea and vomiting. Gastroenterology, 120 : 263-286, 2001 (PMID : 11208736)
 
15) Chiu L, et al : Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV) : a systematic review and meta-analysis. Support Care Cancer, 24 : 2381-2392, 2016 (PMID : 26768437)
 
16) 「基本がわかる 漢方医学講義」 (日本漢方医学教育協議/編), 羊土社, 2020
 
17) 礒濱洋一郎 : 作用メカニズムの最新知見 五苓散のアクアポリンを介した水分代謝調節メカニズム. 「特集 五苓散をめぐる臨床応用と最新知見」, 漢方医学, 35 : 186-189, 2011
 
18) 眞喜志牧里子, 他 : 嘔吐を伴う小児の胃腸炎における五苓散坐剤の有効性に関する検討. 日本病院薬剤師会雑誌, 55 : 183-187, 2019
Medical*Online
19) 西恵子 : 小児の嘔吐に対する五苓散坐剤の効果-ドンペリドン坐剤との比較-. 日本病院薬剤師会雑誌, 34 : 1173-1176, 1998
Medical*Online
20) Gan TJ, et al : Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg, 118 : 85-113, 2014 (PMID : 24356162)
 
P.99 掲載の参考文献
1) Noiesen E, et al : Constipation--prevalence and incidence among medical patients acutely admitted to hospital with a medical condition. J Clin Nurs, 23 : 2295-2302, 2014 (PMID : 24372682)
 
2) Lewis SJ & Heaton KW : Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol, 32 : 920-924, 1997 (PMID : 9299672)
 
3) ゼリア新薬株式会社 : 新レシカルボン(R) 坐剤 インタビューフォーム
 
4) EAファーマ株式会社 : テレミンソフト(R) 坐薬 インタビューフォーム
 
5) サンファーマ株式会社 : プルゼニド(R) 錠 インタビューフォーム
 
6) Wald A : Constipation : Advances in Diagnosis and Treatment. JAMA, 315 : 185-191, 2016 (PMID : 26757467)
 
7) 健栄製薬株式会社 : ケンエーG 浣腸液 インタビューフォーム
 
8) 持田製薬株式会社 : 酸化マグネシウム錠250 mg/330 mg「モチダ」
 
9) マイランEPD合同会社 : アミティーザ(R) カプセル インタビューフォーム
 
10) 持田製薬株式会社 : モビコール(R) 配合内用剤の製品Q&A
 
11) Portalatin M & Winstead N : Medical management of constipation. Clin Colon Rectal Surg, 25 : 12-19, 2012 (PMID : 23449608)
 
12) アステラス製薬 : リンゼス(R) インタビューフォーム
 
13) 持田製薬株式会社 : グーフィス(R) 錠5mgの製品Q&A https://med.mochida.co.jp/qa/gof-h.html
 
14) 塩野義製薬株式会社 : スインプロイク(R) インタビューフォーム
 
15) 帝人ファーマ株式会社 : ラキソベロン(R) 内用液/ラキソベロン(R) 錠 インタビューフォーム
 
16) Coggrave M, et al : Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev : CD002115, 2014 (PMID : 24420006)
 
17) 「ステップ ビヨンド レジデント 6 救急で必ず出合う疾患編 Part 3」 (林 寛之/著), 羊土社, 2010
 
「慢性便秘症診療ガイドライン 2017」 (日本消化器病学会関連研究会 慢性便秘の診断・治療研究会/編), 南江堂, 2017
 
P.102 掲載の参考文献
1) 酸化マグネシウム製剤製造販売会社 : 酸化マグネシウム製剤適正使用に関するお願い-高マグネシウム血症-. 2020 https://www.pmda.go.jp/files/000235889.pdf
 
2) 味村俊樹 : 慢性便秘症治療薬の正しい使い方. レジデントノート, 21 : 715-723, 2019
Medical*Online
3) 神蔵巧, 他 : 慢性便秘症患者におけるルビプロストンの安全性・有効性の検討 : 特定使用成績調査48週間のデータによる検討, 診療と新薬 ; 57 : 201-215,2020
 
P.111 掲載の参考文献
1) Donnelly K, et al : Benzodiazepines, Z-drugs and the risk of hip fracture : A systematic review and meta-analysis. PLoS One, 12 : e0174730, 2017 (PMID : 28448593)
 
2) Torii H, et al : Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients : A Case-Crossover Study. Biol Pharm Bull, 43 : 925-931, 2020 (PMID : 32475914)
 
3) Agar MR, et al : Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care : A Randomized Clinical Trial. JAMA Intern Med, 177 : 34-42, 2017 (PMID : 27918778)
PubMed
4) Herzig SJ, et al : Antipsychotics and the Risk of Aspiration Pneumonia in Individuals Hospitalized for Nonpsychiatric Conditions : A Cohort Study. J Am Geriatr Soc, 65 : 2580-2586, 2017 (PMID : 29095482)
 
5) Basciotta M, et al : Antipsychotics and the Risk of Mortality or Cardiopulmonary Arrest in Hospitalized Adults. J Am Geriatr Soc, 68 : 544-550, 2020 (PMID : 31743435)
 
6) 厚生労働省 : 別紙様式7の3 せん妄ハイリスク患者ケア加算に係るチェックリスト. https://www.mhlw.go.jp/content/12400000/000603917.pdf
 
7) Inouye SK, et al : A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med, 340 : 669-676, 1999 (PMID : 10053175)
 
8) Hatta K, et al : Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors. J Clin Psychiatry, 81 : doi : 10.4088/JCP.19m12865, 2019 (PMID : 31851436)
 
9) Oh ES, et al : Antipsychotics for preventing delirium in hospitalized adults : A systematic review. Ann Intern Med, 171 : 474-484, 2019 (PMID : 31476766)
 
10) Devlin JW, et al : Efficacy and safety of quetiapine in critically ill patients with delirium : a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med, 38 : 419-427, 2010 (PMID : 19915454)
 
11) Lambert J, et al : Discharge from hospital with newly administered antipsychotics after intensive care unit delirium-Incidence and contributing factors. J Crit Care, 61 : 162-167, 2021 (PMID : 33171333)
 
P.119 掲載の参考文献
1) 箕岡真子 : 『臨床倫理』 へのいざない ACP (アドバンスケアプラニング) とDNAR指示. 老年看護学, 23 (2) : 28-33, 2019
Medical*Online
2) American Medical Association : Guidelines for the appropriate use of do-not-resuscitate orders. Council on Ethical and Judicial Affairs, American Medical Association. JAMA, 265 : 1868-1871, 1991 (PMID : 2005737)
 
3) 医学書院HP : 日本集中治療医学会「DNAR指示のあり方についての勧告」 (丸藤哲) https://www.igaku-shoin.co.jp/paper/archive/y2017/PA03224_03#bun (最終アクセス : 2022年11月)
 
4) 新井達潤 : 終末期患者に対するdo-not-resuscitate order (DNR指示) はどうあるべきか--日本蘇生学会, 日本集中治療医学会, 日本麻酔学会評議員に対するアンケート調査. 麻酔, 43 : 600-611, 1994
 
5) Sanders A, et al : Partial do-not-resuscitate orders : A hazard to patient safety and clinical outcomes? Crit Care Med, 39 : 14-18, 2011 (PMID : 21057317)
 
6) 日本臨床倫理学会HP : 日本版POLST (DNAR指示を含む) 作成指針 https://square.umin.ac.jp/j-ethics/workinggroup.htm#2 (最終アクセス : 2022年11月)
 
7) 健康長寿ネットHP : 事前指示 https://www.tyojyu.or.jp/net/byouki/shumatsuiryou/jizen-shiji.html (最終アクセス : 2022年11月)
 
8) 厚生労働省HP : 「人生会議」してみませんか https://www.mhlw.go.jp/stf/newpage_02783.html (最終アクセス : 2022年11月)
 
9) 「人生の最終段階における医療・ケアの決定プロセスに関するガイドライン (改訂平成30年3月) 」 (厚生労働省), 2018 https://www.mhlw.go.jp/file/04-Houdouhappyou-10802000-Iseikyoku-Shidouka/0000197701.pdf
 
P.130 掲載の参考文献
1) Lilly CM, et al : Thrombosis prophylaxis and mortality risk among critically ill adults. Chest, 146 : 51-57, 2014 (PMID : 24722879)
 
2) Barbar S, et al : A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism : the Padua Prediction Score. J Thromb Haemost, 8 : 2450-2457, 2010 (PMID : 20738765)
 
3) Center for Outcomes Research : Bleeding Risk Factors https://www.outcomes-umassmed.org/IMPROVE/risk_score/bleeding/index.html
 
4) Decousus H, et al : Factors at admission associated with bleeding risk in medical patients : findings from the IMPROVE investigators. Chest, 139 : 69-79, 2011 (PMID : 20453069)
 
5) 日本循環器学会 : 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版) https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf (2022年11月閲覧)
 
6) Kahn SR, et al : Prevention of VTE in nonsurgical patients : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141 : e195S-e226S, 2012 (PMID : 22315261)
 
7) Ho KM & Tan JA : Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation, 128 : 1003-1020, 2013 (PMID : 23852609)
 
8) CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration, et al : Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3) : a multicentre randomised controlled trial. Lancet.10 ; 382 : 516-24. 2013 (PMID : 23727163)
 
9) Dennis M, et al : Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1) : a multicentre, randomised controlled trial. Lancet, 373 : 1958-1965, 2009 (PMID : 19477503)
 
10) Evans L, et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med, 49 : e1063-e1143, 2021 (PMID : 34605781)
 
11) Marin-Corral J, et al : Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest, 159 : 58-72, 2021 (PMID : 32687909)
 
12) 「ICU完全攻略トラブルシューティング 162」 (清水敬樹/著), 中外医学社, 2015
 
13) Anderson CS, et al : Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke. N Engl J Med, 376 : 2437-2447, 2017 (PMID : 28636854)
 
14) 日本呼吸器学会, 医療・介護関連肺炎診療ガイドライン作成委員会 : 医療・介護関連肺炎 (NHCAP) 診療ガイドライン, 2011
 
15) Maldonado JR, et al : Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients : A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome. Alcohol Alcohol, 50 : 509-518, 2015 (PMID : 25999438)
 
16) Sullivan JT, et al : Assessment of alcohol withdrawal : the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict, 84 : 1353-1357, 1989 (PMID : 2597811)
 
17) Daeppen JB, et al : Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal : a randomized treatment trial. Arch Intern Med, 162 : 1117-1121, 2002 (PMID : 12020181)
 
18) Mayo-Smith MF : Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA, 278 : 144-151, 1997 (PMID : 9214531)
 
19) ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm, 56 : 347-379, 1999 (PMID : 10690219)
 
20) Cook DJ, et al : Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med, 330 : 377-381, 1994 (PMID : 8284001)
 
21) Cook D & Guyatt G : Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. N Engl J Med, 378 : 2506-2516, 2018 (PMID : 29949497)
 
22) Barletta JF, et al : Stress Ulcer Prophylaxis. Crit Care Med, 44 : 1395-1405, 2016 (PMID : 27163192)
 
23) MacLaren R, et al : Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med, 174 : 564-574, 2014 (PMID : 24535015)
 
24) Ye Z, et al : Gastrointestinal bleeding prophylaxis for critically ill patients : a clinical practice guideline. BMJ, 368 : l6722, 2020 (PMID : 31907223)
 
25) Toews I, et al : Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database Syst Rev, 6 : CD008687, 2018 (PMID : 29862492)
 
26) Wang Y, et al : Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients : an updated systematic review and network meta-analysis of randomized trials. Intensive Care Med, 46 : 1987-2000, 2020 (PMID : 32833040)
 

Part 2 持参薬はどうする ? - 基礎疾患のある患者の病棟管理

P.135 掲載の参考文献
1) 松原知康 : Neurology for Primary Care 第4回神経疾患患者が入院してきたら「J-COSMO Vol.1 No.4」, 715-722, 中外医学社, 2019
 
P.143 掲載の参考文献
1) Koracevic G, et al : Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies. Hypertens Res, 43 : 591-596, 2020 (PMID : 32382156)
 
2) Momomura SI, et al : Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure. Circ J, 82 : 141-147, 2017 (PMID : 28768917)
 
3) Tamaki Y, et al : Lower In-Hospital Mortality With Beta-Blocker Use at Admission in Patients With Acute Decompensated Heart Failure. J Am Heart Assoc, 10 : e020012, 2021 (PMID : 34180244)
 
4) Bohm M, et al : Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment : data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial. Crit Care Med, 39 : 940-944, 2011 (PMID : 21283007)
 
5) Fonarow GC, et al : Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure : findings from the OPTIMIZE-HF program. J Am Coll Cardiol, 52 : 190-199, 2008 (PMID : 18617067)
PubMed
6) Bollano E, et al : Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart, 89 : 621-624, 2003 (PMID : 12748215)
PubMed
7) Di Santo P, et al : Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock : a subgroup analysis of the DOREMI trial. Crit Care, 25 : 289, 2021 (PMID : 34376218)
 
8) van Loon LM, et al : Hemodynamic response to β-blockers in severe sepsis and septic shock : A review of current literature. J Crit Care, 50 : 138-143, 2019 (PMID : 30540967)
 
9) Fuchs C, et al : Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth, 119 : 616-625, 2017 (PMID : 29121280)
 
10) DeMott JM, et al : Effects of Chronic Antihypertensives on Vasopressor Dosing in Septic Shock. Ann Pharmacother, 52 : 40-47, 2018 (PMID : 28799416)
 
11) Morelli A, et al : Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock : a randomized clinical trial. JAMA, 310 : 1683-1691, 2013 (PMID : 24108526)
 
12) Oda N, et al : Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 12 : 1119-1124, 2017 (PMID : 28435245)
 
13) Yang YL, et al : Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease : a systematic review and meta-analysis. Eur Heart J, 41 : 4415-4422, 2020 (PMID : 33211823)
 
14) Jabbour A, et al : Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease : a randomized crossover trial. J Am Coll Cardiol, 55 : 1780-1787, 2010 (PMID : 20413026)
 
15) Iakovou I, et al : Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 293 : 2126-2130, 2005 (PMID : 15870416)
 
16) Claessen BE, et al : Stent thrombosis : a clinical perspective. JACC Cardiovasc Interv, 7 : 1081-1092, 2014 (PMID : 25341705)
 
17) Loh JP, et al : Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents. Am J Cardiol, 113 : 1968-1976, 2014 (PMID : 24767975)
 
18) 日本循環器学会, 他 : 2020年JCSガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法, 2020 https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf
 
19) 日本循環器学会, 他 : 日本循環器学会/日本不整脈心電学会合同ガイドライン 2020年改訂版 不整脈薬物治療ガイドライン, 2020 https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf
 
20) Moscucci M, et al : Predictors of major bleeding in acute coronary syndromes : the Global Registry of Acute Coronary Events (GRACE). Eur Heart J, 24 : 1815-1823, 2003 (PMID : 14563340)
 
21) Eisenberg MJ, et al : Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation, 119 : 1634-1642, 2009 (PMID : 19289638)
 
22) Sung JJ, et al : Continuation of low-dose aspirin therapy in peptic ulcer bleeding : a randomized trial. Ann Intern Med, 152 : 1-9, 2010 (PMID : 19949136)
 
23) Macdonald RL : Management of Intracranial Hemorrhage in the Anticoagulated Patient. Neurosurg Clin N Am, 29 : 605-613, 2018 (PMID : 30223973)
 
24) Al-Shahi Salman R, et al : Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage : Extended Follow-up of the RESTART Randomized Clinical Trial. JAMA Neurol, 78 : 1179-1186, 2021 (PMID : 34477823)
 
25) Phillips BG, et al : Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy, 17 : 1238-1245, 1997 (PMID : 9399606)
 
26) Rogenstein C, et al : An international view of how recent-onset atrial fibrillation is treated in the emergency department. Acad Emerg Med, 19 : 1255-1260, 2012 (PMID : 23167856)
 
27) Ono K, et al : JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias. Circ J : doi : 10.1253/circj.CJ-20-1212, 2022 (PMID : 35283400)
 
28) January CT, et al : 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 64 : e1-76, 2014 (PMID : 24685669)
 
29) Hindricks G, et al : 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) : The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J, 42 : 373-498, 2021 (PMID : 32860505)
 
30) Morganroth J : Risk factors for the development of proarrhythmic events. Am J Cardiol, 59 : 32E-37E, 1987 (PMID : 3107364)
 
31) Echt DS, et al : Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med, 324 : 781-788, 1991 (PMID : 1900101)
 
32) Claveau D, et al : Complications Associated With Nitrate Use in Patients Presenting With Acute Pulmonary Edema and Concomitant Moderate or Severe Aortic Stenosis. Ann Emerg Med, 66 : 355-362.e1, 2015 (PMID : 26002298)
PubMed
33) McMurray JJ, et al : Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med, 371 : 993-1004, 2014 (PMID : 25176015)
 
34) Docherty KF, et al : Sacubitril/Valsartan : Neprilysin Inhibition 5 Years After PARADIGM-HF. JACC Heart Fail, 8 : 800-810, 2020 (PMID : 33004114)
 
35) Swedberg K, et al : Ivabradine and outcomes in chronic heart failure (SHIFT) : a randomised placebo-controlled study. Lancet, 376 : 875-885, 2010 (PMID : 20801500)
 
36) Tsutsui H, et al : JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure. Circ J, 85 : 2252-2291, 2021 (PMID : 34588392)
 
37) Bauersachs J : Heart failure drug treatment : the fantastic four. Eur Heart J, 42 : 681-683, 2021 (PMID : 33447845)
 
P.148 掲載の参考文献
1) 加藤真吾, 他 : アンケートを用いた寛解期潰瘍性大腸炎患者に対する経口5-ASA製剤のアドヒアランス調査. 日消誌, 112 (10) : 1819-1829, 2015
Medical*Online
2) Reimer C, et al : Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology, 137 : 80-7, 87.e1, 2009 (PMID : 19362552)
 
3) 藤城光弘, 他 : 非静脈瘤性上部消化管出血における内視鏡診療ガイドライン, 57 (8) : 1648-1666, 2015
 
4) 「消化性潰瘍診療ガイドライン 2020 改訂第3版」 (日本消化器病学会/編), pp16-18, 南江堂, 2020
 
5) 藤本一眞, 他 : 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン, 日本消化器内視鏡学会雑誌, 54 (7) : 1547-1558, 2017
 
6) Sung JJ, et al : Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding : an update 2018. Gut, 67 : 1757-1768, 2018 (PMID : 29691276)
 
7) Chavez-Tapia NC, et al : Meta-analysis : antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-an updated Cochrane review. Aliment Pharmacol Ther, 34 : 509-518, 2011 (PMID : 21707680)
 
8) MSDマニュアルプロフェッショナル版 2019 : 経鼻胃管またはイレウス管挿入 https://www.msdmanuals.com/ja-jp/プロフェッショナル/01-消化管疾患/消化管の診断と治療に関する手技/経鼻胃管またはイレウス管挿入
 
P.153 掲載の参考文献
1) Kuwano A, et al : Serum α-fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct-acting antiviral treatment. J Viral Hepat, 29 : 35-42, 2022 (PMID : 34661320)
 
2) 日本肝臓学会 肝炎診療ガイドライン作成委員会 : B型肝炎治療ガイドライン (第3.4版), 2021 https://www.jsh.or.jp/lib/files/medical/guidelines/jsh_guidlines/B_v3.4.pdf
 
3) 日本耳鼻咽喉科学会 : 突発性難聴, 顔面神経麻痺等のステロイド治療におけるB型肝炎ウイルス再活性化防止に関する指針 (第2版), 2020 http://www.jibika.or.jp/members/information/info_nanchou_2.html
 
P.163 掲載の参考文献
1) Global Initiative for Asthma : Global Strategy for Asthma Management and Prevention (2022 Update) https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf
 
2) 「喘息予防・管理ガイドライン 2021」 (一般社団法人日本アレルギー学会喘息ガイドライン専門部会/監), 協和企画, 2021
 
3) 独立行政法人 環境再生保全機構 : 成人ぜん息の基礎知識 正しい吸入方法を身につけよう https://www.erca.go.jp/yobou/zensoku/basic/adult/control/inhalers/feature01.html
 
4) Rajan JP, et al : Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients : A meta-analysis of the literature. J Allergy Clin Immunol, 135 : 676-81.e1, 2015 (PMID : 25282015)
 
5) 「改題改定喘息バイブル【電子版付】」 (倉原優/著), 日本医事新報社, 2020
 
6) ヴィアトリス製薬株式会社 : セレコックス(R) 添付文書
 
7) あゆみ製薬株式会社 : カロナール(R) 添付文書
 
8) Global Initiative for Chronic Obstructive Lung Disease (GOLD) : GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD : 2022 Report https://goldcopd.org/2022-gold-reports/
 
9) O'Driscoll BR, et al : BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax, 72 : ii1-ii90, 2017 (PMID : 28507176)
 
10) 「COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第5版」 (日本呼吸器学会COPDガイドライン第5版作成委員会/編), メディカルレビュー社, 2018
 
P.170 掲載の参考文献
1) Toru M, et al : Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J Nerv Ment Dis, 169 : 324-327, 1981 (PMID : 6111584)
 
2) Newman EJ, et al : The parkinsonism-hyperpyrexia syndrome. Neurocrit Care, 10 : 136-140, 2009 (PMID : 18712508)
 
3) Rajan S, et al : Movement Disorders Emergencies. Semin Neurol, 39 : 125-136, 2019 (PMID : 30743298)
 
4) 「内服薬 経管投与ハンドブック 第4版」 (藤島一郎/監, 倉田なおみ/編), じほう, 2020
 
5) 「パーキンソン病診療ガイドライン 2018」 (日本神経学会/監), 医学書院, 2018
 
6) 大塚製薬株式会社 : ニュープロ(R) パッチ インタビューフォーム
 
7) Tomlinson CL, et al : Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord, 25 : 2649-2653, 2010 (PMID : 21069833)
 
8) Fabbri M, et al : Opicapone for the treatment of Parkinson's disease : A review of a new licensed medicine. Mov Disord, 33 : 1528-1539, 2018 (PMID : 30264443)
 
9) Schade S, et al : Levodopa Equivalent Dose Conversion Factors : An Updated Proposal Including Opicapone and Safinamide. Mov Disord Clin Pract, 7 : 343-345, 2020 (PMID : 32258239)
 
10) Wullner U, et al : Transdermal rotigotine for the perioperative management of Parkinson's disease. J Neural Transm (Vienna), 117 : 855-859, 2010 (PMID : 20535621)
 
11) Rabinak CA, et al : Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol, 67 : 58-63, 2010 (PMID : 20065130)
 
12) Pondal M, et al : Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry, 84 : 130-135, 2013 (PMID : 22933817)
 
13) Samuel M, et al : Management of impulse control disorders in Parkinson's disease : Controversies and future approaches. Mov Disord, 30 : 150-159, 2015 (PMID : 25607799)
 
14) Yu XX, et al : Dopamine agonist withdrawal syndrome : A comprehensive review. J Neurol Sci, 374 : 53-55, 2017 (PMID : 28104232)
 
15) McKee HR, et al : Stress as a seizure precipitant : Identification, associated factors, and treatment options. Seizure, 44 : 21-26, 2017 (PMID : 28063791)
 
16) Garcia DA, et al : Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med, 168 : 63-69, 2008 (PMID : 18195197)
 
17) Raunso J, et al : Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. Eur Heart J, 33 : 1886-1892, 2012 (PMID : 22199117)
PubMed
18) Vene N, et al : Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry. PLoS One, 11 : e0156943, 2016 (PMID : 27280704)
PubMed
19) Maulaz AB, et al : Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol, 62 : 1217-1220, 2005 (PMID : 16087761)
 
20) Oscarsson A, et al : To continue or discontinue aspirin in the perioperative period : a randomized, controlled clinical trial. Br J Anaesth, 104 : 305-312, 2010 (PMID : 20150346)
 
21) Garcia Rodriguez LA, et al : Increased risk of stroke after discontinuation of acetylsalicylic acid : a UK primary care study. Neurology, 76 : 740-746, 2011 (PMID : 21270415)
 
22) Douketis JD, et al : Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med, 373 : 823-833, 2015 (PMID : 26095867)
 
23) Kim DH, et al : Dementia medications and risk of falls, syncope, and related adverse events : meta-analysis of randomized controlled trials. J Am Geriatr Soc, 59 : 1019-1031, 2011 (PMID : 21649634)
 
24) Gillman PK : Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth, 95 : 434-441, 2005 (PMID : 16051647)
 
25) Wang RZ, et al : Serotonin syndrome : Preventing, recognizing, and treating it. Cleve Clin J Med, 83 : 810-817, 2016 (PMID : 27824534)
 
26) 「重症筋無力症/ランバート・イートン筋無力症候群診療ガイドライン 2022」 (日本神経学会/監), 南江堂, 2022 https://www.neurology-jp.org/guidelinem/pdf/mg_02.pdf
 
27) Sanders DB, et al : International consensus guidance for management of myasthenia gravis : Executive summary. Neurology, 87 : 419-425, 2016 (PMID : 27358333)
 
28) Argov Z, et al : Ampicillin may aggravate clinical and experimental myasthenia gravis. Arch Neurol, 43 : 255-256, 1986 (PMID : 3947272)
 
29) Jordan H, et al : Management of Insomnia and Anxiety in Myasthenia Gravis. J Neuropsychiatry Clin Neurosci, 31 : 386-391, 2019 (PMID : 31177904)
 
30) Barreto LC, et al : Epidemiologic Study of Charcot-Marie-Tooth Disease : A Systematic Review. Neuroepidemiology, 46 : 157-165, 2016 (PMID : 26849231)
 
31) Charcot-Marie-Tooth Association : Neurotoxic Medications https://www.cmtausa.org/living-with-cmt/managing-cmt/medications/
 
32) Ahmed N, et al : Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke, 31 : 1250-1255, 2000 (PMID : 10835440)
 
33) Ballard C, et al : Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet, 351 : 1032-1033, 1998 (PMID : 9546516)
 
34) McKeith IG, et al : Diagnosis and management of dementia with Lewy bodies : Fourth consensus report of the DLB Consortium. Neurology, 89 : 88-100, 2017 (PMID : 28592453)
 
35) Kapasi A, et al : Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol, 134 : 171-186, 2017 (PMID : 28488154)
 
36) Robinson JL, et al : Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain, 141 : 2181-2193, 2018 (PMID : 29878075)
 
37) American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc, 67 : 674-694, 2019 (PMID : 30693946)
 
38) O'Mahony D, et al : STOPP/START criteria for potentially inappropriate prescribing in older people : version 2. Age Ageing, 44 : 213-218, 2015 (PMID : 25324330)
 
39) 「高齢者の安全な薬物療法ガイドライン 2015」 (日本老年医学会 日本医療研究開発機構研究費・高齢者の薬物治療の安全性に関する研究 研究班/編), メジカルビュー社, 2015
 
40) 松原知康 : Neurology for Primary Care 第4回神経疾患患者が入院してきたら「J-COSMO Vol.1 No.4」, 715-722, 中外医学社, 2019
 
P.177 掲載の参考文献
1) 「糖尿病専門医研修ガイドブック 改訂第8版」 (日本糖尿病学会/編), 診断と治療社, 2020
 
2) Wolpert HA, et al : Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes : implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care, 36 : 810-816, 2013 (PMID : 23193216)
 
3) サノフィ株式会社 : ランタス(R) 注 インタビューフォーム
 
4) キッセイ薬品工業株式会社 : ミニリンメルト(R) OD錠 インタビューフォーム
 
5) あすか製薬株式会社 : メルカゾール(R) 注 インタビューフォーム
 
6) 「甲状腺専門医ガイドブック 改訂第2版」 (日本甲状腺学会/編), 診断と治療社, 2018
 
7) あすか製薬株式会社 : チラーヂン(R) S静注液 インタビューフォーム
 
8) Kyriazopoulou V, et al : Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement therapy. J Clin Endocrinol Metab, 59 : 1204-1206, 1984 (PMID : 6490796)
 
P.186 掲載の参考文献
1) Nesher L, et al : The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection, 42 : 5-13, 2014 (PMID : 23975584)
 
2) Klastersky J, et al : Management of febrile neutropaenia : ESMO Clinical Practice Guidelines. Ann Oncol, 27 : v111-v118, 2016 (PMID : 27664247)
 
3) Sanchez-Ramon S, et al : Primary and Secondary Immunodeficiency Diseases in Oncohaematology : Warning Signs, Diagnosis, and Management. Front Immunol, 10 : 586, 2019 (PMID : 30984175)
 
4) Weber JS, et al : Safety Profile of Nivolumab Monotherapy : A Pooled Analysis of Patients With Advanced Melanoma. J Clin Oncol, 35 : 785-792, 2017 (PMID : 28068177)
 
5) Carson JL, et al : Red blood cell transfusion : a clinical practice guideline from the AABB*. Ann Intern Med, 157 : 49-58, 2012 (PMID :)
 
6) Kaufman RM, et al : Platelet transfusion : a clinical practice guideline from the AABB. Ann Intern Med, 162 : 205-213, 2015 (PMID : 25383671)
 
7) Barcellini W, et al : Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia : a GIMEMA study of 308 patients. Blood, 124 : 2930-2936, 2014 (PMID : 25232059)
 
8) Provan D, et al : Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv, 3 : 3780-3817, 2019 (PMID : 31770441)
 
「レジデントノート増刊 Vol. 20 No.17 免疫不全患者の発熱と感染症をマスターせよ! 」 (原田壮平/編), 羊土社, 2019
 
Darnell EP, et al : Immune-Related Adverse Events (irAEs) : Diagnosis, Management, and Clinical Pearls. Curr Oncol Rep, 22 : 39, 2020 (PMID : 32200442)
 
Charshafian S, et al : Rapid Fire : Infectious Disease Emergencies in Patients with Cancer. Emerg Med Clin North Am, 36 : 493-516, 2018 (PMID : 30037437)
 
P.192 掲載の参考文献
1) 白鷺病院ホームページ : 透析患者に対する投薬ガイドライン http://www.shirasagi-hp.or.jp/goda/fmly/gate.html
 
2) 「慢性腎臓病に対する食事療法基準 2014年版」 (日本腎臓学会/編), 東京医学社, 2014
 
3) Allon M : Hyperkalemia in end-stage renal disease : mechanisms and management. J Am Soc Nephrol, 6 : 1134-1142, 1995 (PMID : 8589279)
 
4) 「腎障害患者におけるヨード造影剤使用に関するガイドライン 2018」 (日本腎臓学会, 他/編), 東京医学社, 2018
 
5) Moran SM & Myers BD : Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int, 27 : 928-937, 1985 (PMID : 4021321)
 
6) 日本透析医学会 : 慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン. 日本透析学会会誌, 44 (9) : 855-937, 2011
 
7) El Ters M, et al : Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas : a case-control study in hemodialysis patients. Am J Kidney Dis, 60 : 601-608, 2012 (PMID : 22704142)
 
8) Itkin M, et al : Peripherally inserted central catheter thrombosis--reverse tapered versus nontapered catheters : a randomized controlled study. J Vasc Interv Radiol, 25 : 85-91.e1, 2014 (PMID : 24268631)
 
P.198 掲載の参考文献
1) 「腹膜透析ガイドライン 2019」 (腹膜透析ガイドライン改訂ワーキンググループ/編), 医学図書出版, 2019
 
2) Oliveira LG, et al : Peritonitis in recent years : clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center. Int Urol Nephrol, 44 : 1529-1537, 2012 (PMID : 22302733)
 
3) Wu HH, et al : Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients. PLoS One, 8 : e71532, 2013 (PMID : 23936514)
 
4) Li PK, et al : ISPD peritonitis guideline recommendations : 2022 update on prevention and treatment. Perit Dial Int, 42 : 110-153, 2022 (PMID : 35264029)
 
P.204 掲載の参考文献
1) Woodcock T, et al : Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency : Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia, 75 : 654-663, 2020 (PMID : 32017012)
 
2) Garcia Vidal C, et al : Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis, 40 : 756-759, 2005 (PMID : 15714425)
 
Rushworth RL, et al : Adrenal Crisis. N Engl J Med, 381 : 852-861, 2019 (PMID : 31461595)
 
Vera C & Rueda ZV : Transmission and Colonization of Pneumocystis jirovecii. J Fungi (Basel), 7 : doi : 10.3390/jof7110979, 2021 (PMID : 34829266)
 
「関節リウマチ治療におけるメトトレキサート (MTX) 診療ガイドライン 2016年改訂版」, 羊土社, pp6, 2016
 
P.206 掲載の参考文献
1) 「関節リウマチ治療におけるメトトレキサート (MTX) 診療ガイドライン 2016年改訂版」, 羊土社, pp6, 2016
 
P.215 掲載の参考文献
1) Goodnick PJ, et al : Lithium elimination half-life and duration of therapy. Clin Pharmacol Ther, 29 : 47-50, 1981 (PMID : 7460473)
 
2) Lewis G, et al : Maintenance or Discontinuation of Antidepressants in Primary Care. N Engl J Med, 385 : 1257-1267, 2021 (PMID : 34587384)
 
3) Durgam S, et al : Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia : A randomized, double-blind, placebo-controlled trial. Schizophr Res, 176 : 264-271, 2016 (PMID : 27427558)
 
4) 日本精神科評価尺度研究会HP : 向精神薬の等価換算 2017年版 http://jsprs.org/toukakansan/2017ver/index.php
 
5) Lader M : Benzodiazepine harm : how can it be reduced? Br J Clin Pharmacol, 77 : 295-301, 2014 (PMID : 22882333)
 
6) Omichi C, et al : Association between discontinuation of benzodiazepine receptor agonists and post-operative delirium among inpatients with liaison intervention : A retrospective cohort study. Compr Psychiatry, 104 : 152216, 2021 (PMID : 33227543)
 
7) Copeland LA, et al : Postoperative complications in the seriously mentally ill : a systematic review of the literature. Ann Surg, 248 : 31-38, 2008 (PMID : 18580204)
 
8) Ganzini L, et al : Delirium and decisional incapacity in veterans with schizophrenia and medical illness. Gen Hosp Psychiatry, 34 : 506-509, 2012 (PMID : 22632926)
 
9) National Institute for Health and Clinical Excellence : Guideline for the Management of Refeeding Syndrome (Adults) 2nd edition. NHS Foundation Trust, 2009
 
10) Philip M, et al : Anorexia nervosa in adults and adolescents : The refeeding syndrome. UpToDate(R), 2022
 
11) Philip M, et al : Anorexia nervosa in adults and adolescents : Medical complications and their management. UpToDate(R), 2022
 
12) 最高裁判所判例集. 事件番号 : 平成17 (あ) 202 https://www.courts.go.jp/app/hanrei_jp/detail2?id=50093 (2022年11月アクセス)
 

Part 3 病棟でのマイナートラブル

P.226 掲載の参考文献
1) Langdon J, et al : Vertebral compression fractures--new clinical signs to aid diagnosis. Ann R Coll Surg Engl, 92 : 163-166, 2010 (PMID : 19995486)
 
2) 手島隆志, 元津康彦 : 急性期脊椎圧迫骨折の疼痛知覚部位の検討. 中部整災誌, 58 (1) : 109-110, 2015
 
Lake ET, et al : Patient falls : Association with hospital Magnet status and nursing unit staffing. Res Nurs Health, 33 : 413-425, 2010 (PMID : 20824686)
 
「WHOグローバルレポート 高齢者の転倒予防」 (鈴木みずえ, 他/監訳), クオリティケア, 2010
 
大高洋平 : 第I章 転倒の基本的な知識と考え方. 「回復期リハビリテーションの実践戦略 活動と転倒」, 医歯薬出版, 2016
 
第12章 高齢者骨折の特殊性. 「骨折・脱臼 第4版」 (冨士川恭輔, 鳥巣岳彦/編), 南山堂, 2018
 
「フローチャート整形外科診断」 (藤井達也/著), 中外医学社, 2020
 
「骨折ハンター レントゲン×非整形外科医」 (増井伸高/著), 中外医学社, 2019
 
「Gノート増刊 Vol. 8 No.2 : 整形診療 for プライマリ・ケア診療所」 (海透優太, 他/編), 羊土社, 2021
 
「教えて! 救急 整形外科疾患のミカタ」 (斉藤究/編), 羊土社, 2014
 
「ERの骨折 : まちがいのない軽症外傷の評価と処置」 (太田凡, 許勝栄/編), シービーアール, 2010
 
P.234 掲載の参考文献
1) 奥田比佐志 : 導尿法. 外科治療, 78 (6) : 1060-1064, 1998
Medical*Online
2) Kashefi C, et al : Incidence and prevention of iatrogenic urethral injuries. J Urol, 179 : 2254-7 ; discussion 2257, 2008 (PMID : 18423712)
 
3) Shinozaki S, et al : Loxoprofen inhibits facilitated micturition reflex induced by acetic acid urinary bladder infusion of the rats. Biomed Res, 26 : 29-33, 2005 (PMID : 15806981)
 
4) 河谷正仁, 他 : 排尿メカニズムにおける膀胱知覚神経系の役割. 排尿障害プラクティス, 12 (4) : 265-269, 2004
Medical*Online
「コツをおぼえて必ずできる! 体腔穿刺」 (真弓俊彦/編), 羊土社, 2008
 
P.239 掲載の参考文献
1) 「医療事故の再発防止に向けた提言 第6号. 栄養剤投与目的に行われた胃管挿入に係る死亡事例の分析」 (医療事故調査・支援センター 一般社団法人 日本医療安全調査機構), 2018 https://www.medsafe.or.jp/uploads/uploads/files/teigen-06.pdf (2022年11月閲覧)
 
2) Taylor SJ : Methods of Estimating Nasogastric Tube Length : All, Including "NEX," Are Unsafe. Nutr Clin Pract, 35 : 864-870, 2020 (PMID : 32406552)
 
酒井達也, 井澤純一 : 【コラム (3)】胃管留置-合わせ技で挿入位置もしっかり確認し, 合併症を回避せよ. Hospitalist, 8 : 569-573, 2020
 
P.243 掲載の参考文献
1) 「"うまくいく" PEG (ペグ) 胃瘻 : 鍵を握るナースのケア エキスパートナース2012年3月号」, 照林社, 2012
 
NPO法人PDN (Patient Doctors Network) : 胃ろう入門-胃ろう (PEG) とは? http://www.peg.or.jp/eiyou/peg/about.html
 
P.250 掲載の参考文献
1) Bauer TM, et al : Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA, 285 : 313-319, 2001 (PMID : 11176841)
 
2) Samarkos M, et al : The 3-day rule for stool cultures : should all patients with haematological malignancies be excluded? Clin Microbiol Infect, 24 : 1342.e1-1342.e3, 2018 (PMID : 30017969)
 
3) Curran J, et al : Estimating daily antibiotic harms : an umbrella review with individual study meta-analysis. Clin Microbiol Infect, 28 : 479-490, 2022 (PMID : 34775072)
 
4) Hogenauer C, et al : Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med, 355 : 2418-2426, 2006 (PMID : 17151365)
 
5) Polage CR, et al : Nosocomial diarrhea : evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis, 55 : 982-989, 2012 (PMID : 22700831)
 
6) Shimura S, et al : Diarrhea caused by proton pump inhibitor administration : comparisons among lansoprazole, rabeprazole, and omeprazole. Curr Ther Res Clin Exp, 73 : 112-120, 2012 (PMID : 24648598)
 
7) Eggleston W, et al : Notes from the Field : Cardiac Dysrhythmias After Loperamide Abuse-New York, 2008-2016. MMWR Morb Mortal Wkly Rep, 65 : 1276-1277, 2016 (PMID : 27855148)
 
8) Porter JC, et al : Further echoes of the Spanish lady. Lancet, 348 : 694, 1996 (PMID : 8782791)
 
9) Hurley BW, et al : The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med, 162 : 2177-2184, 2002 (PMID : 12390059)
 
P.253 掲載の参考文献
1) Manabe YC, et al : Clostridium difficile colitis : an efficient clinical approach to diagnosis. Ann Intern Med, 123 : 835-840, 1995 (PMID : 7486465)
 
2) Aichinger E, et al : Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol, 46 : 3795-3797, 2008 (PMID : 18784320)
PubMed
3) Cardona DM, et al : Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol, 46 : 3686-3689, 2008 (PMID : 18845820)
 
P.261 掲載の参考文献
1) Pallin DJ, et al : Seizure visits in US emergency departments : epidemiology and potential disparities in care. Int J Emerg Med, 1 : 97-105, 2008 (PMID : 19384659)
 
2) Farhidvash F, et al : Patients visiting the emergency room for seizures : insurance status and clinic follow-up. Seizure, 18 : 644-647, 2009 (PMID : 19783460)
 
3) Fields MC, et al : Hospital-onset seizures : an inpatient study. JAMA Neurol, 70 : 360-364, 2013 (PMID : 23319087)
 
4) Legriel S, et al : Functional outcome after convulsive status epilepticus. Crit Care Med, 38 : 2295-2303, 2010 (PMID : 20890201)
 
5) Scholtes FB, et al : Generalized convulsive status epilepticus : causes, therapy, and outcome in 346 patients. Epilepsia, 35 : 1104-1112, 1994 (PMID : 7925159)
 
6) Trinka E, et al : A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 56 : 1515-1523, 2015 (PMID : 26336950)
 
7) Steinert T, et al : Epileptic Seizures Under Antidepressive Drug Treatment : Systematic Review. Pharmacopsychiatry, 51 : 121-135, 2018 (PMID : 28850959)
 
8) Wanleenuwat P, et al : Antibiotic-induced epileptic seizures : mechanisms of action and clinical considerations. Seizure, 81 : 167-174, 2020 (PMID : 32827980)
 
9) Cannon JP, et al : The risk of seizures among the carbapenems : a meta-analysis. J Antimicrob Chemother, 69 : 2043-2055, 2014 (PMID : 24744302)
 
10) Glauser T, et al : Evidence-Based Guideline : Treatment of Convulsive Status Epilepticus in Children and Adults : Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr, 16 : 48-61, 2016 (PMID : 26900382)
 
11) Kapur J, et al : Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. N Engl J Med, 381 : 2103-2113, 2019 (PMID : 31774955)
 

付録 薬剤便利帖

P.266 掲載の参考文献
1) 「腎機能低下時に最も注意が必要な薬剤投与量一覧 (2022年改訂35版) 」 (一般社団法人日本腎臓病薬物療法学会/編), 2022
 
2) 「薬剤性腎障害診療ガイドライン 2016」 (薬剤性腎障害の診療ガイドライン作成委員会/編), 2016
 
P.271 掲載の参考文献
1) 「内服薬 経管投与ハンドブック 第4版」 (藤島一郎/監, 倉田なおみ/編), じほう, 2020
 

書評

最近チェックした商品履歴

Loading...